Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does the DPP4 Inhibitor Sitagliptin Have a Role in Preventing Type 2 Diabetes- A Randomised Controlled Study.

NCT01038648 is registered in ClinicalTrials.gov with India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals as lead sponsor.

NCT NCT01038648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01038648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does the DPP4 Inhibitor Sitagliptin Have a Role in Preventing Type 2 Diabetes- A Randomised Controlled Study.
Lead sponsor
India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals
Phase
Phase 3
Overall status
Withdrawn
Start date
December 31, 2011
Completion date
December 31, 2014
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes